<VariationArchive RecordType="classified" VariationID="12021" VariationName="NM_000282.4(PCCA):c.1846-2_1852del" VariationType="Deletion" Accession="VCV000012021" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-12-25" DateCreated="2021-12-23" MostRecentSubmission="2021-12-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27060" VariationID="12021">
      <GeneList>
        <Gene Symbol="PCCA" FullName="propionyl-CoA carboxylase subunit alpha" GeneID="5095" HGNC_ID="HGNC:8653" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100089093" stop="100530435" display_start="100089093" display_stop="100530435" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="100741268" stop="101182690" display_start="100741268" display_stop="101182690" Strand="+" />
          </Location>
          <OMIM>232000</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000282.4(PCCA):c.1846-2_1852del</Name>
      <CanonicalSPDI>NC_000013.11:100449246:TTTAGTGTCTTT:TTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q32.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="100449247" stop="100449255" display_start="100449247" display_stop="100449255" variantLength="9" positionVCF="100449246" referenceAlleleVCF="TTTTAGTGTC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="101101501" stop="101101509" display_start="101101501" display_stop="101101509" variantLength="9" positionVCF="101101500" referenceAlleleVCF="TTTTAGTGTC" alternateAlleleVCF="T" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.101101504_101101512del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.101101504_101101512del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.100449250_100449258del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.100449250_100449258del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008768.1" sequenceAccession="NG_008768" sequenceVersion="1" change="g.365168_365176del">
            <Expression>NG_008768.1:g.365168_365176del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000282.4" sequenceAccession="NM_000282" sequenceVersion="4" change="c.1846-2_1852del" MANESelect="true">
            <Expression>NM_000282.4:c.1846-2_1852del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001178004.2" sequenceAccession="NM_001178004" sequenceVersion="2" change="c.1846-2_1852del">
            <Expression>NM_001178004.2:c.1846-2_1852del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352605.2" sequenceAccession="NM_001352605" sequenceVersion="2" change="c.1845+23519_1845+23527del">
            <Expression>NM_001352605.2:c.1845+23519_1845+23527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352606.2" sequenceAccession="NM_001352606" sequenceVersion="2" change="c.1702-2_1708del">
            <Expression>NM_001352606.2:c.1702-2_1708del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352610.2" sequenceAccession="NM_001352610" sequenceVersion="2" change="c.901-2_907del">
            <Expression>NM_001352610.2:c.901-2_907del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352611.2" sequenceAccession="NM_001352611" sequenceVersion="2" change="c.900+23519_900+23527del">
            <Expression>NM_001352611.2:c.900+23519_900+23527del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352612.2" sequenceAccession="NM_001352612" sequenceVersion="2" change="c.757-2_763del">
            <Expression>NM_001352612.2:c.757-2_763del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127692.3" sequenceAccession="NM_001127692" sequenceVersion="3" change="c.1768-2_1774del">
            <Expression>NM_001127692.3:c.1768-2_1774del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352607.2" sequenceAccession="NM_001352607" sequenceVersion="2" change="c.1768-2_1774del">
            <Expression>NM_001352607.2:c.1768-2_1774del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352608.2" sequenceAccession="NM_001352608" sequenceVersion="2" change="c.1624-2_1630del">
            <Expression>NM_001352608.2:c.1624-2_1630del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001352609.2" sequenceAccession="NM_001352609" sequenceVersion="2" change="c.1846-2_1852del">
            <Expression>NM_001352609.2:c.1846-2_1852del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001574" Type="splice acceptor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="232000.0002" DB="OMIM" />
        <XRef Type="rs" ID="2152925644" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff provided an HGVS expression for allelic variant 232000.0002 based on the sequence reported in Figure 2 of the paper by Richard et al., 1997 (PubMed 9385377).</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000282.4(PCCA):c.1846-2_1852del AND Propionic acidemia" Accession="RCV000012801" Version="25">
        <ClassifiedConditionList TraitSetID="3247">
          <ClassifiedCondition DB="MedGen" ID="C0268579">Propionic acidemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-11-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-12-23" MostRecentSubmission="2021-12-23">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">9385377</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3247" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5805" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Propionic acidemia</ElementValue>
                <XRef ID="Propionic+acidemia/5994" DB="Genetic Alliance" />
                <XRef ID="HP:0003571" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0011628" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycinemia, ketotic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hyperglycinemia with ketoacidosis and leukopenia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ketotic hyperglycinemia</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PROP</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="467" />
                <XRef ID="467" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The spectrum of propionic acidemia (PA) ranges from neonatal-onset to late-onset disease. Neonatal-onset PA, the most common form, is characterized by a healthy newborn with poor feeding and decreased arousal in the first few days of life, followed by progressive encephalopathy of unexplained origin. Without prompt diagnosis and management, this is followed by progressive encephalopathy manifesting as lethargy, seizures, or coma that can result in death. It is frequently accompanied by metabolic acidosis with anion gap, lactic acidosis, ketonuria, hypoglycemia, hyperammonemia, and cytopenias. Individuals with late-onset PA may remain asymptomatic and suffer a metabolic crisis under catabolic stress (e.g., illness, surgery, fasting) or may experience a more insidious onset with the development of multiorgan complications including vomiting, protein intolerance, failure to thrive, hypotonia, developmental delays or regression, movement disorders, or cardiomyopathy. Isolated cardiomyopathy can be observed on rare occasion in the absence of clinical metabolic decompensation or neurocognitive deficits. Manifestations of neonatal and late-onset PA over time can include growth impairment, intellectual disability, seizures, basal ganglia lesions, pancreatitis, and cardiomyopathy. Other rarely reported complications include optic atrophy, hearing loss, premature ovarian insufficiency, and chronic renal failure.</Attribute>
                <XRef ID="NBK92946" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22593918</ID>
                <ID Source="BookShelf">NBK92946</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2017">
                <URL>https://managementguidelines.net/guidelines.php/104/PROP%20Nutrition%20Guidelines/Version%201.2</URL>
                <CitationText>PROP Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Elevated%20C3%20Acylcarnitine%20PA%20and%20MA.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C3 Acylcarnitine, Propionic Acidemia (PA) and Methylmalonic Acidemia (MMA), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C3-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Propionic and Methylmalonic Acidemia: C3 Elevated, 2022</CitationText>
              </Citation>
              <XRef ID="35" DB="Orphanet" />
              <XRef ID="C0268579" DB="MedGen" />
              <XRef ID="MONDO:0011628" DB="MONDO" />
              <XRef Type="MIM" ID="606054" DB="OMIM" />
              <XRef Type="primary" ID="HP:0003571" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33041" SubmissionDate="2021-12-20" DateLastUpdated="2021-12-23" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="232000.0002_PROPIONIC ACIDEMIA" title="PCCA, 9-BP DEL, 1771IVS, -2_PROPIONIC ACIDEMIA" />
        <ClinVarAccession Accession="SCV000033041" DateUpdated="2021-12-23" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Richard et al. (1997) identified a 9-bp (AGTGTCTTT) deletion in the intron upstream of nucleotide 1771 in the PCCA gene in a 16-year-old patient with a late-onset form of propionic acidemia (606054). The diagnosis was made at 6 years of age. Response to restricted dietary protein was favorable, and psychomotor development was adequate. The 9-bp deletion, which affected the invariant AG dinucleotide in the 3-prime splice acceptor site and the first 7 bases of the exon, was present in heterozygous form.</Attribute>
              <Citation>
                <ID Source="PubMed">9385377</ID>
              </Citation>
              <XRef DB="OMIM" ID="606054" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PCCA" />
          </GeneList>
          <Name>PCCA, 9-BP DEL, 1771IVS, -2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">9-BP DEL, 1771IVS, -2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="232000.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PROPIONIC ACIDEMIA</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33041" TraitType="Disease" MappingType="Name" MappingValue="PROPIONIC ACIDEMIA" MappingRef="Preferred">
        <MedGen CUI="C0268579" Name="Propionic acidemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

